Location: Biologics Development Module
Project Number: 3022-32000-026-010-S
Project Type: Non-Assistance Cooperative Agreement
Start Date: Sep 1, 2023
End Date: Aug 31, 2024
Objective:
Advance the development of veterinary vaccine countermeasures to prevent, control, and respond to Rift Valley Fever incursions.
Develop an ELISA based assay for detection of Rift Valley Fever Virus infection.
Approach:
Task 1. Cooperator designs constructs and expresses RVFV Gn and N proteins in baculovirus expression system.
Task 2. Cooperator designs constructs and expresses RVFV Gn and N proteins in E. coli-based expression system.
Task 3. ARS will evaluate expressed proteins for suitability in development of antibody-based diagnostic assay.
